05843439 is referenced by 100 patents and cites 3 patents.

Disclosed herein are therapeutic treatment protocols designed for the treatment of B cell lymphoma. These protocols are based upon therapeutic strategies which include the use of administration of immunologically active mouse/human chimeric anti-CD20 antibodies, radiolabeled anti-CD20 antibodies, and cooperative strategies comprising the use of chimeric anti-CD20 antibodies and radiolabeled anti-CD20 antibodies.

Title
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
Application Number
978891
Publication Number
5843439
Application Date
June 7, 1995
Publication Date
December 1, 1998
Inventor
William H Rastetter
16067 Puerta Del Sol, Rancho Sante Fe, 92067
CA, US
Mitchell E Reff
4166 Combe Way, San Diego, 92122
CA, US
Roland A Newman
4311 Robbins St., San Diego, 92122
CA, US
John E Leonard
1960 Avenida Joaquin, Encinitas, 92024
CA, US
Nabil Hanna
3255 Fortuna Ranch Rd., Olivenhain, 92024
CA, US
Darrell R Anderson
1851 Navajo Pl., Escondido, 92029
CA, US
Agent
Burns Doane Swecker & Mathis
IPC
C07K 16/30
A61K 51/00
A61K 39/395
A61K 39/00
View Original Source